Healthcare Sales & Marketing Network News: Lava

Searching News Database: Lava

HSMN NewsFeed - 14 Dec 2021
Medtronic INVOS(TM) 7100 Cerebral/Somatic Oximetry System receives 510(k) clearance for pediatric indications
Devices Monitoring FDA

HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 17 Jun 2021
Irrimax Receives FDA Clearance for Irrisept(R) as an Antimicrobial Wound Lavage for US Market
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Jun 2021
Bausch & Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE(TM) Clinical Decision Support Software
Devices Ophthalmology

HSMN NewsFeed - 10 May 2021
Olympus Launches Line of Airway Mobilescopes
Devices FDA Product Launch

HSMN NewsFeed - 4 May 2021
Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories
Diagnostics Product Launch

HSMN NewsFeed - 22 Apr 2021
Ortho Dermatologics Announces Statistically Significant Topline Results From Second Pivotal Phase 3 Clinical Trial Evaluating IDP-126 Gel In Acne Vulgaris
Biopharmaceuticals Dermatology

HSMN NewsFeed - 13 Apr 2021
Bausch & Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 7 Apr 2021
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
Devices Ophthalmology FDA

HSMN NewsFeed - 8 Mar 2021
Solta Medical Announces the U.S. Launch of The Clear + Brilliant(R) Touch Laser
Devices Dermatology Product Launch

HSMN NewsFeed - 9 Dec 2020
Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.
Devices Oncology Venture Capital

HSMN NewsFeed - 21 Sep 2020
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 17 Sep 2020
Novo Ventures co-leads US $83m series C financing in Lava Therapeutics
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 17 Aug 2020
Bausch & Lomb Launches Innovative Bausch & Lomb INFUSE(TM) Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
Devices Ophthalmology Product Launch

HSMN NewsFeed - 4 Aug 2020
ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To Initiate Clinical Trial Of Niclosamide In COVID-19 Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Jun 2020
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 Jun 2020
Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 27 May 2020
Bausch & Lomb Announces The European Launch Of LuxSmart(TM) And LuxGood(TM) Preloaded Intraocular Lenses
Devices Ophthalmology Product Launch

HSMN NewsFeed - 7 May 2020
OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
Diagnostics FDA

HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Biopharmaceuticals Litigation Licensing

HSMN NewsFeed - 11 Feb 2020
Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis
Biopharmaceuticals Drug Delivery Dermatology

HSMN NewsFeed - 20 Dec 2019
Bausch Health Licenses Novaliq's NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 20 Dec 2019
Bausch Health Announces Resolution Of BRYHALI(R) (Halobetasol Propionate) Lotion, 0.01%, Intellectual Property Litigation With Glenmark
Biopharmaceuticals Dermatology Litigation

HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Oct 2019
Bausch Health Licenses Clearside Biomedical's XIPERE(TM) (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2019
OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
Devices Neurology Venture Capital

HSMN NewsFeed - 25 Mar 2019
Inovio Appoints Global Commercial Leader to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Nov 2018
Cumberland Pharmaceuticals To Acquire VIBATIV(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 24 Oct 2018
Bausch & Lomb To Launch First-In-Class Surgical Support Applications For Stellaris Elite(TM) Vision Enhancement System On IBM Cloud
Devices Ophthalmology Surgery Product Launch

HSMN NewsFeed - 8 Oct 2018
Bausch Health's BRYHALI(TM) (halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 24 Aug 2018
Ortho Dermatologics Receives FDA Approval For ALTRENO(TM) (tretinoin 0.05%) Lotion For Acne
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 16 May 2018
EIP Pharma Secures $20.5 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 8 May 2018
Valeant Will Become Bausch Health Companies Inc.
Biopharmaceuticals Dermatology

HSMN NewsFeed - 2 May 2018
Bausch & Lomb ULTRA(R) Contact Lenses Receive FDA Approval for Extended Wear Indication
Devices Ophthalmology FDA

HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2018
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics
Devices Mergers & Acquisitions

HSMN NewsFeed - 19 Feb 2018
GenePOC Launches Its revogene(TM) Instrument and GBS LB Test in Canada
Diagnostics Product Launch

HSMN NewsFeed - 29 Jan 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2017
Bausch & Lomb Begins Distribution Of VYZULTA(TM) (latanoprostene bunod ophthalmic solution), 0.024% To U.S. Wholesalers
Biopharmaceuticals Ophthalmology Product Launch

HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology

HSMN NewsFeed - 13 Nov 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Nov 2017
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisition Fund I, L.P.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Nov 2017
Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2017
Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ(TM) (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
Biopharmaceuticals Dermatology

HSMN NewsFeed - 4 Oct 2017
Solta Medical Receives FDA 510(k) Clearance for Thermage FLX(TM) System, Newest Generation Skin Smoothing Technology
Devices Dermatology FDA

HSMN NewsFeed - 29 Sep 2017
Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Jul 2017
Valeant Announces U.S. Launch of SILIQ(TM) (brodalumab) Injection
Biopharmaceuticals Dermatology Product Launch

HSMN NewsFeed - 20 Jul 2017
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 17 Jul 2017
Valeant Agrees To Sell Obagi Medical Products Business
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 11 Jul 2017
Prometic Announces Positive Long Term Clinical Data on Ryplazym(TM) in Plasminogen Congenital Deficiency and Provides Regulatory Update
Biopharmaceuticals

HSMN NewsFeed - 3 Jul 2017
Theranica Raises $6M to Combat Migraine
Devices Neurology Venture Capital

HSMN NewsFeed - 8 Jun 2017
Valeant Announces Sale of iNova Pharmaceuticals for $930 Million
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 May 2017
Bausch & Lomb Introduces renu(R) Advanced Formula Multi-Purpose Solution
Biopharmaceuticals Ophthalmology Product Launch

HSMN NewsFeed - 17 May 2017
Statement Regarding Xifaxan Intellectual Property Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 10 May 2017
Savara Announces Expedited U.S. Molgradex Development Strategy
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Apr 2017
Bausch & Lomb Receives 510(k) Clearance From FDA For Vitesse(TM), The First And Only Hypersonic, Open-Port Vitrectomy System
Devices Ophthalmology FDA

HSMN NewsFeed - 24 Apr 2017
Millennium Medical Technologies (MMT) First in the Nation to Receive FDA Clearance for a Reusable Fat Collection and Grafting System
Devices Surgery FDA

HSMN NewsFeed - 21 Apr 2017
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ(TM) (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology

HSMN NewsFeed - 30 Mar 2017
Bausch & Lomb ULTRA(R) for Astigmatism Contact Lenses Introduced
Devices Ophthalmology Product Launch

HSMN NewsFeed - 21 Mar 2017
George Bickerstaff Elected to Inovio’s Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Mar 2017
Bausch & Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
Devices Ophthalmology Product Launch

HSMN NewsFeed - 21 Feb 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 16 Feb 2017
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 13 Dec 2016
Valeant Appoints William D. Humphries As EVP, Dermatology
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 6 Dec 2016
Theresa LaVallee, Ph.D., Joins Celldex Therapeutics’ Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Nov 2016
GSK Receives FDA Approval for Expanded Indication for Flulaval(R) Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Nov 2016
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Oct 2016
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Sep 2016
Next Science(TM) Irrigation Solution Gains FDA Approval
Biopharmaceuticals Wound Care FDA

HSMN NewsFeed - 23 Sep 2016
AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 22 Aug 2016
Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 4 Aug 2016
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jul 2016
Journal of Urology Publishes Results of Exact Imaging's Initial PRI-MUS(TM) Protocol using High Resolution Micro-Ultrasound
Devices Urology Oncology

HSMN NewsFeed - 1 Jul 2016
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 21 Jun 2016
Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva
Biopharmaceuticals

HSMN NewsFeed - 16 Jun 2016
Valeant Pharmaceuticals Announces Launch Of New PreserVision(R) AREDS 2 Formula + Multivitamin
Biopharmaceuticals Ophthalmology Product Launch

HSMN NewsFeed - 26 May 2016
Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 5 May 2016
Valeant Pharmaceuticals Announces Collaboration Between Bausch & Lomb And IBM
Devices Surgery Ophthalmology

HSMN NewsFeed - 3 May 2016
Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 13 Apr 2016
Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Mar 2016
First Human Results with V-Wave’s Interatrial Shunt Published in The Lancet
Devices Cardiology

HSMN NewsFeed - 9 Mar 2016
Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 3 Mar 2016
Valeant Pharmaceuticals Comments On Management Change
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 29 Jan 2016
Viacoram(R) now approved in Canada as a new first line treatment in hypertension
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 25 Jan 2016
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 28 Dec 2015
Valeant Announces J. Michael Pearson Will Be On Medical Leave of Absence
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 18 Dec 2015
Gelesis Closes $31.5 Million Growth Financing
Biopharmaceuticals Endocrinology Venture Capital

HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 Sep 2015
Valeant And AstraZeneca To Partner On Brodalumab
Biopharmaceuticals Dermatology Licensing Distribution

HSMN NewsFeed - 20 Aug 2015
Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Jul 2015
Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 29 Apr 2015
Valeant Announces CFO Succession Plan And Additional Executive Appointment
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 28 Apr 2015
Strauss Surgical Announces Health Canada Regulatory Approval of the Strauss Optiks(R) HD Endoscopes
Devices Surgery Regulatory Distribution

HSMN NewsFeed - 9 Feb 2015
PerkinElmer Elects Sylvie Grégoire to its Board of Directors
Devices Personnel

HSMN NewsFeed - 25 Nov 2014
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 25 Sep 2014
Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 17 Jul 2014
Bausch + Lomb's VICTUS(R) Femtosecond Laser Platform Receives 510(k) Clearance from FDA for Lens Fragmentation Procedure
Devices Ophthalmology FDA

HSMN NewsFeed - 26 Mar 2014
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Regenerative Medicine FDA

HSMN NewsFeed - 3 Feb 2014
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 31 Jan 2014
Valeant Pharmaceuticals Announces Approval of Retin-A Micro(R) Microsphere 0.08%
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 24 Jan 2014
Valeant Pharmaceuticals International, Inc. Completes Acquisition of Solta Medical, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions

HSMN NewsFeed - 15 Jan 2014
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions

HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Biopharmaceuticals Devices Mergers & Acquisitions

HSMN NewsFeed - 9 Dec 2013
Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
Devices Diagnostics Personnel

HSMN NewsFeed - 15 Nov 2013
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu(R) Cream, 1%
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 28 Oct 2013
Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
Biopharmaceuticals Litigation

HSMN NewsFeed - 18 Oct 2013
Valeant Pharmaceuticals Announces Award In Anacor Dispute
Biopharmaceuticals Litigation

HSMN NewsFeed - 3 Oct 2013
Valeant Pharmaceuticals Announces Approval Of Jublia(R) For The Treatment Of Onychomycosis In Canada
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 2 Oct 2013
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
Devices Dermatology Regulatory

HSMN NewsFeed - 16 Aug 2013
Additional GlaxoSmithKline quadrivalent intramuscular influenza vaccine approved by FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2013
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch & Lomb
Biopharmaceuticals Ophthalmology Mergers & Acquisitions

HSMN NewsFeed - 29 Jul 2013
DJO Surgical, a DJO Global Company, Announces the First TaperFill Hip Stem Implanted
Devices Orthopaedic

HSMN NewsFeed - 22 Jul 2013
ETView Medical, Ltd., and MEDITRADE al. s ro, (MEDITRADE) Execute Distribution Agreement
Devices Distribution

HSMN NewsFeed - 9 Jan 2013
Velomedix Receives Health Canada Approval for VELOCITY Pilot Study and Bolsters Leadership Team
Devices Cardiology Regulatory

HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
Regenerative Medicine Orthopaedic Personnel

HSMN NewsFeed - 18 Jul 2012
Lantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
Diagnostics Devices Radiology Personnel

HSMN NewsFeed - 4 Oct 2011
Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2011
Astellas and Theravance Announce European Marketing Authorization for VIBATIV(R) for Nosocomial Pneumonia Caused by MRSA
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Aug 2011
Labopharm Inc. Enters Into an Agreement to Be Acquired by Paladin Labs Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Jul 2011
Lantheus Medical Imaging Announces Management Change
Devices Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2011
Valeant Pharmaceuticals Agrees to Acquire Dermik
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 24 May 2011
Sorin Group Announces First North American Implant of the Freedom Solo Pericardial Aortic Valve
Devices Cardiology

HSMN NewsFeed - 14 Mar 2011
Labopharm Announces Appointment of New President & CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Mar 2011
Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease
Biopharmaceuticals Radiology Cardiology FDA

HSMN NewsFeed - 25 Jan 2011
Labopharm Announces Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2011
Angelini Labopharm Confirms Appointment of Mary Anne Heino as President
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jan 2011
Lantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR(R) and DEFINITY(R)
Biopharmaceuticals Radiology Distribution

HSMN NewsFeed - 7 Dec 2010
CONMED Corporation Awarded Multiple Contracts With HealthTrust Purchasing Group
Devices Group Purchasing

HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Biopharmaceuticals

HSMN NewsFeed - 26 Jul 2010
MAQUET Cardiovascular Launches Advanced VASOVIEW Technology for Endoscopic Vessel Harvesting Procedures in Cardiac Surgery
Devices Cardiology

HSMN NewsFeed - 7 Apr 2010
Medtronic Launches New Frontal Handpiece for Its Hydrodebrider System
Devices

HSMN NewsFeed - 17 Mar 2010
Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
Devices Oncology

HSMN NewsFeed - 9 Mar 2010
Scivanta Medical Corporation Announces Results for Initial Clinical Trial for the Scivanta Cardiac Monitoring System
Devices Cardiology Monitoring

HSMN NewsFeed - 8 Mar 2010
ThermalTherapeutic Systems Announces FDA Clearance of the VERATHERM(TM) Portable Hyperthermic Perfusion System
Devices FDA

HSMN NewsFeed - 17 Feb 2010
Lantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as Vice President, Sales and Marketing
Biopharmaceuticals Radiology Personnel

HSMN NewsFeed - 20 Jan 2010
Lantheus Medical Imaging, Inc. Launches ABLAVAR (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent
Biopharmaceuticals Radiology

HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2009
Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
Devices Oncology

HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals

HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Jul 2009
Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2009
Control Medical Closes Series A Financing with Strategic Investors
Devices Surgery Venture Capital

HSMN NewsFeed - 25 Feb 2009
OxyHeal Announces Contract For Design, Manufacture, and Installation of a Multiplace Hyperbaric Chamber System
Devices

HSMN NewsFeed - 3 Feb 2009
Warnex Offers New Personalized Medicine Service: K-ras Mutation Analysis for Colorectal Cancer
Diagnostics Oncology

HSMN NewsFeed - 31 Dec 2008
Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Sep 2008
Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Aug 2008
Bristol-Myers Squibb Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) as a Treatment Option for Chronic Hepatitis B
Biopharmaceuticals

HSMN NewsFeed - 8 Jul 2008
Power Medical Interventions, Inc. Files Special 510(k) for i45V 45mm Vascular Stapler and Reload Cartridge
Devices Surgery FDA

HSMN NewsFeed - 26 Jun 2008
Power Medical Interventions, Inc. Launches the iDrive S -- Intelligent Surgical Instrument
Devices Surgery

HSMN NewsFeed - 28 May 2008
Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (FOSAMAX(R))
Biopharmaceuticals

HSMN NewsFeed - 5 May 2008
GE Healthcare Introduces New 3.0T MR Scanner; Breakthrough Technology Provides Radiologists with Powerful Applications for Increased Clinical Capability
Devices Radiology

HSMN NewsFeed - 28 Apr 2008
Labopharm Appoints Dr. Claire Brullé as Senior Vice-President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Apr 2008
3M Acquires Les Entreprises Solumed Inc.
Devices Acquisitions

HSMN NewsFeed - 1 Apr 2008
Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Biopharmaceuticals

HSMN NewsFeed - 5 Mar 2008
FDA Accepts for Review Theravance's Complete Response to Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Feb 2008
Labopharm's Once-Daily Tramadol Approved in South Korea and Australia
Biopharmaceuticals Regulatory Distribution

HSMN NewsFeed - 1 Feb 2008
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
Biopharmaceuticals

HSMN NewsFeed - 28 Jan 2008
Paradigm Medical Industries to Market Proprietary Electrophysiology Device for Early Detection of Glaucoma
Devices Ophthalmology Distribution

HSMN NewsFeed - 24 Jan 2008
Labopharm Receives FDA Response To Recent Appeal Of Approvable Letter For Once-Daily Tramadol
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jan 2008
NovaBay Pharmaceutical's Investigational New Drug Application (IND) for the Prevention of Catheter Associated Urinary Tract Infections Cleared by FDA
Biopharmacuticals

HSMN NewsFeed - 27 Dec 2007
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Dec 2007
Power Medical Interventions, Inc. Receives FDA 510(k) Marketing Clearance for iDrive Intelligent Surgical Instruments
Devices Surgery FDA

HSMN NewsFeed - 5 Dec 2007
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
Biopharmaceuticals

HSMN NewsFeed - 21 Nov 2007
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Nov 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Oct 2007
European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Oct 2007
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Oct 2007
Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Oct 2007
Labopharm appeals FDA's decision on once-daily tramadol
Biopharmaceuticals Pain Management FDA

HSMN NewsFeed - 24 Sep 2007
Labopharm provides update on U.S. regulatory process for once-daily Tramadol
Biopharmaceuticals

HSMN NewsFeed - 24 Sep 2007
Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2007
Theravance Retains Full Ownership of Gastrointestinal Motility Dysfunction Program and TD-1792 Antibiotic
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 28 Aug 2007
Neurochem provides information on cash position
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Aug 2007
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 31 Jul 2007
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jul 2007
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 12 Jul 2007
Labopharm and Paladin Complete Canadian Licensing and Distribution Agreement for Labopharm's Once-Daily Tramadol Product
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 11 Jul 2007
Labopharm Completes South Korean Licensing and Distribution Agreement for Once-Daily Tramadol
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 9 Jul 2007
New Medtronic Implantable Cardiac Monitor Gives Physicians Valuable Insights into the Cause of Unexplained Fainting
Devices Cardiology Regulatory

HSMN NewsFeed - 3 Jul 2007
Scivanta Medical Corporation Enters Into Agreements for the Development of the Hickey Cardiac Monitoring System
Devices Cardiology Monitoring

HSMN NewsFeed - 29 Jun 2007
Labopharm meets with FDA to discuss second Approvable Letter for once-daily tramadol
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2007
Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Jun 2007
Neurochem receives third recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 18 Jun 2007
Health Canada approves new chemotherapy treatment for patients with metastatic colorectal cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Jun 2007
Labopharm's Once-Daily Tramadol Approved for Sale in Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Jun 2007
Canadian hospitals participate in first-ever clinical trial to evaluate new pacemaker system designed for use in MRI machines
Devices Cardiology

HSMN NewsFeed - 7 Jun 2007
Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Trazodone
Biopharmaceuticals

HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 31 May 2007
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 30 May 2007
Theravance Announces Acceptance of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 May 2007
Leading Urologists Present Studies at the American Urological Association Supporting Use of the NMP22(R) BladderChek(R) Test for Diagnosing and Managing Bladder Cancer
Diagnostics Urology Oncology

HSMN NewsFeed - 22 May 2007
Hana Biosciences Announces Vice President Appointment in Regulatory Affairs and Quality Assurance
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 May 2007
Verathon(R) Inc., Maker of BladderScan(R), Launches FloPoint(R) Elite Uroflow System at AUA
Devices Urology

HSMN NewsFeed - 1 May 2007
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Apr 2007
ThermoGenesis Announces Record Revenues and Key Executive Changes
Devices Personnel

HSMN NewsFeed - 4 Apr 2007
Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results
Biopharmaceuticals Dermatology

HSMN NewsFeed - 3 Apr 2007
Cardica Receives 510(k) Clearance for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
Devices Cardiology Surgery FDA

HSMN NewsFeed - 20 Feb 2007
Theravance Announces FDA Acceptance of Telavancin NDA
Biopharmaceuticals

HSMN NewsFeed - 15 Feb 2007
Labopharm appoints Vice President Sales and Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Feb 2007
Neurochem receives second recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Feb 2007
Neurochem announcement regarding the completion of its North American phase III clinical trial for tramiprosate (ALZHEMED(TM)) for the treatment of Alzheimer's disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 Jan 2007
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
Biopharmaceuticals

HSMN NewsFeed - 28 Dec 2006
Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of Medicine
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Dec 2006
Labopharm submits response to approvable letter for once-daily Tramadol to FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Nov 2006
Accentia Biopharmaceuticals Commences Fast-Tracked Phase 3 Clinical Trial of SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Nov 2006
Neurochem receives recommendations from data safety monitoring boards to continue phase III clinical trials for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Nov 2006
Tramiprosate (ALZHEMED(TM)) Phase II Clinical Results Published in Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Oct 2006
TYZEKA(TM) (telbivudine) Approved by U.S. Food and Drug Administration (FDA) as a New Treatment for Patients with Chronic Hepatitis B
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Oct 2006
Salix Pharmaceuticals Reports American College of Gastroenterology Update
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 18 Oct 2006
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006
Devices Interventional Cardiology

HSMN NewsFeed - 10 Oct 2006
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Oct 2006
Important safety information about KETEK (telithromycin)
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
Labopharm receives approvable letter from FDA for once-daily tramadol
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 21 Sep 2006
Telbivudine Approved in Switzerland for Chronic Hepatitis B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Sep 2006
Labopharm Appoints Mark D'Souza as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2006
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jul 2006
Biopsy Study Shows Combination of Long-Acting Beta2-Agonist and Low Steroid Dose in Advair Diskus(R) 100/50mcg Maintains Control of Airway Inflammation
Biopharmaceuticals

HSMN NewsFeed - 18 Jul 2006
Theravance and Astellas Add Japan to Collaboration on Telavancin, Investigational Antibiotic for Serious Infections
Biopharmaceuticals

HSMN NewsFeed - 16 May 2006
Theravance Announces Enrollment of Last Patient in Phase 3 Complicated Skin and Skin Structure Infections Clinical Program With Investigational Antibiotic, Telavancin
Biopharmaceuticals

HSMN NewsFeed - 9 May 2006
Labopharm Enters Into Distribution Agreement with Grunenthal for Once-Daily Tramadol in Belgium
Biopharmaceuticals Licensing Distribution

Return to NewsFeed

Additional items found! 88

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 88 additional stories matching:
Lava
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.